Frank Jaksch

Frank Jaksch, CEO of Chromadex

ChromaDex extends earnings streak, cuts losses in half

By Hank Schultz

ChromaDex Corp. notched its fourth consecutive quarter of record earnings with its Q1 2015 earnings report which it made public this week. The company reported net sales of $5.3 million, an increase of 71% year-over-year. The company also halved its net...

Study shows potential for D-tagatose as sports nutrition ingredient

Study shows potential for D-tagatose as sports nutrition ingredient

By Hank Schultz

D-tagatose, an alternative sweetener that has drifted at the periphery of commercial viability for more than a decade, may have a new lease on life because of its blood sugar management properties, according to a study conducted by ChromaDex.

The devil in GMP details

DSHEA turns 15

The devil in GMP details

By Shane Starling

In the fifth and final installment of this DSHEA special, Frank Jaksch, the president and chief executive officer of Californian-based botanicals reference provider, Chromadex, outlines why he thinks current GMP inspection methodologies are unlikely to...

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers